VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Grand Pharmaceutical & Telix Announce Key Milestone in TLX101 IPAX-2 Phase I Trial for Newly Diagnosed Glioblastoma
Grand Pharmaceutical & Telix Announce Key Milestone in TLX101 IPAX-2 Phase I Trial for Newly Diagnosed Glioblastoma
May 21, 2026 12:55 CST Updated 13:37
Share:
